Filing Details

Accession Number:
0001808805-22-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-10 20:28:04
Reporting Period:
2022-05-09
Accepted Time:
2022-05-10 20:28:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808805 Nautilus Biotechnology Inc. NAUT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378830 M Sujal Patel C/O Nautilus Biotechnology, Inc.
2701 Eastlake Avenue East
Seattle WA 98102
Ceo, President, And Secretary Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-09 50,000 $3.96 9,964,488 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,280,476 Indirect By PFV I, LLC
Common Stock 1,814,035 Indirect By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020
Footnotes
  1. Represents the weighted average share price of an aggregate total of 50,000 shares purchased in the price range of $3.8299 to $4.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
  3. Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.